Evidence map›Paper›PMID 19296113›Full record

Trial reportEuropean radiology2009

Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience.

Jun-Gong Zhao, Yong-Dong Li, Ying-Sheng Cheng, Ming-Hua Li, Ni-Wei Chen, Wei-Xiong Chen, Ke-Zhong Shang

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in European radiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. ACG Clinical Guidelines: Diagnosis and Management of Achalasia.The American journal of gastroenterology · 2020
    Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Endoscopic treatment of esophageal achalasia.World journal of gastrointestinal endoscopy · 2016
    Article
  12. Clinical management of achalasia: current state of the art.Clinical and experimental gastroenterology · 2016
    Review
  13. Article
  14. Idiopathic (primary) achalasia: a review.Orphanet journal of rare diseases · 2015
    Review
  15. Observational
  16. Management of primary achalasia: The role of endoscopy.World journal of gastrointestinal endoscopy · 2015
    Review
  17. Self-expandable metal stents for achalasia: Thinking out of the box!World journal of gastrointestinal endoscopy · 2015
    Review
  18. Article
  19. Review
  20. 2011 update on esophageal achalasia.World journal of gastroenterology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jun-Gong ZhaoDepartment of Radiology, The Tenth Affiliated People's Hospital, Shanghai Tong Ji University, No. 301, Middle Yan Chang Road, Shanghai, China.
Yong-Dong Li
Ying-Sheng Cheng
Ming-Hua Li
Ni-Wei Chen
Wei-Xiong Chen
Ke-Zhong Shang
Shanghai Tenth People's Hospital · CNShanghai Jiao Tong University · CNShanghai Sixth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To prospectively evaluate the long-term clinical safety and efficacy of a newly designed self-expanding metallic stent (SEMS) in the treatment of patients with achalasia. Seventy-five patients with achalasia were treated with a temporary SEMS with a 30-mm diameter. The SEMSs were placed under fluoroscopic guidance and removed by gastroscopy 4-5 days after stent placement. Follow-up data focused on dysphagia score, technique and clinical success, clinical remissions and failures, and complications and was performed at 6 months, 1 year, and within 3 to 5 years, 5 to 8 years, 8 to 10 years, and >10 years postoperatively. Stent placement was technically successful in all patients. Complications included stent migration (n = 4, 5.33%), chest pain (n = 28, 38.7%), reflux (n = 15, 20%), and bleeding (n = 9, 12%). No perforation or 30-day mortality occurred. Clinical success was achieved in all patients 1 month after stent removal. The overall remission rates at 6 months, 1, 1-3, 3-5, 5-8, 8-10, and >10 year follow-up periods were 100%, 96%, 93.9%, 90.9%, 100%, 100%, and 83.3%, respectively. Stent treatment failed in six patients, and the overall remission rate in our series was 92%. The median and mean primary patencies were 2.8 +/- 0.28 years (95% CI: 2.25-3.35) and 4.28 +/- 0.40 years (95% CI: 3.51-5.05), respectively. The use of temporary SEMSs with 30-mm diameter proved to be a safe and effective approach for managing achalasia with a long-term satisfactory clinical remission rate.

Indexed as

StentsAdolescentAdultAgedChildDeglutition DisordersEsophageal AchalasiaFemaleHumansIntubationLongitudinal StudiesMaleMetalsMiddle AgedPilot ProjectsTreatment OutcomeMetals

Identifiers

PMID19296113
PMCPMC2705705
OpenAlexW2063424814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.